New Impact Factor for Translational Cancer Research: 1.241

We are pleased to announce that the Translational Cancer Research (TCR) has attained its latest impact factor update for the 2020 citation year: 1.241.

Here, we would like to extend our heartfelt gratitude to all our Editorial Team Members, Guest Editors, authors, and reviewers for their valuable contributions.

Read More>>

Translational Cancer Research (TCR) is now a member of Committee on Publication Ethics (COPE)

Starting from July 2021, AME Publishing Company is formally recognized a publisher member of Committee on Publication Ethics (COPE) and over 60 AME-published journals become a member of Committee on Publication Ethics (COPE), as part of AME’s commitment to best practice in scholarly publishing. Translational Cancer Research (TCR) is among the list of COPE membership.

Read More>>

Clinic and Therapeutic Potential of Non-coding RNAs in Cancer

The present special series will explore todays knowledge about the potential role of ncRNAs in the clinic, especially in the liquid biopsy field, and intends to shed light into the future questions to be raised on this matter.

Read More>>

Synergy in Action: Novel Approaches to Combining Radiation Therapy and Immunotherapy

We are pleased to have multiple experts of their respective fields review and discuss the current literature and ongoing trials combining RT and immunotherapy. After reading our edition, I hope you have a better overview of where the oncology field is heading and how together with both RT and immunotherapy, we can continue our efforts to treat and potentially cure our patients with cancer.

Read More>>

Reviewer of the Month(2020-21)

Over the years, many TCR reviewers have made outstanding contributions to the peer review process. They demonstrated professional effort and enthusiasm in their reviews and provided comments that genuinely help the authors to enhance their work.

Hereby, we would like to highlight some of our outstanding reviewers, with a brief interview of their thoughts and insights as a reviewer. Allow us to express our heartfelt gratitude for their tremendous effort and valuable contributions to the scientific process.

Read More>>

TCR 2020 Annual Report

Greetings from Editor-in-Chief and Editorial Office of Translational Cancer Research!

We are pleased to share the 2020 Annual Report of Translational Cancer Research here. 2020 has seen much progress for TCR. We hope 2021 will bring greater things to TCR. We would like to thank you for your support and assistance in improving the journal over the past year, and we certainly look forward to your innovations and contributions in 2021.

We would especially like to express our sincere gratitude to the editorial board members, guest editors, reviewers, authors and readers for all your support and contributions to TCR. We wish you a happy, healthy and prosperous 2021!

Read More>>

Endometrial Cancer

The articles published in this special series can be considered a significant step forward in our knowledge about endometrial cancer and stimulate further discussion among the readers. In particular, the novel pieces of information contained in these articles may lead to important changes in the clinical practice and potential paradigm shifts in the future management of endometrial cancer.

Read More>>

Urothelial Carcinoma

The editors wanted to introduce an interesting and varied topic of UC and would like to thank prominent researchers of bladder cancer around the world who participated in this topic.

Read More>>

Loco-regional Therapy for Metastatic Breast Cancer

Patients with MBC can survive longer without metastatic symptoms when treated with these systemic therapies. However, MBC cannot be cured with ICI or other treatments and the majority of MBC patients will die of their disease. It is important to use all available treatments to obtain maximal control of symptoms, prevent serious complications, and prolong life with minimal disruption of daily activities and quality of life. We endeavor to use fewer powerful drugs, such as hormone therapy and oral agents, and thereby minimize severe adverse events.

Read More>>

Energy Balance, Aging, Obesity, and Cancer

This issue of TCR features a series of articles on the impact of obesity, diabetes, and cancer in the older adult population, focuses on providing a better understanding of the processes noted above, how they may influence cancer promotion and progression, and how they may be mitigated to reduce cancer incidence and its comorbidities.

Read More>>